In 1922, the U.S. Navy identified the naturally occurring asbestos mineral as the most efficient and cost-effective ...

Mesothelioma(a rare and lethal cancer) has been the subject of complex legal disputes because it primarily develops due to ...

For nearly 20 years, mesothelioma treatment options were limited to a single regimen: pemetrexed with a platinum agent. Now, ...

That after-school job turned into a full-time position that helped him pay his way through college and to cover the bill for ...

Vivace Therapeutics Inc. closed a $35 million series D round led by RA Capital Management, an existing investor, and including other backers already on board: Canaan Partners and Cenova Capital.

According to the Center for Disease Control and Prevention (CDC), cancer is the second-leading cause of death in the United ...

A highly experienced cancer nurse has been appointed by Mesothelioma UK at University College London Hospitals NHS Foundation ...

Vivace Therapeutics, Inc., a small molecule discovery and development company developing first-in-class cancer therapies targeting the Hippo pathway, today announced the closing of a $35 million ...

The friendly team of experts at Bridge McFarland LLP strive to support you during an understandably difficult time ...

Ms. Dean celebrates her fifth year on the list. Last year she secured a $45 million mesothelioma verdict against Johnson & Johnson (NYSE: JNJ) and its affiliate Kenvue Inc. She was recognized for ...